Sanjum Sethi, MD MPH
On the web
Overview
Sanjum Sethi, MD, MPH, is an interventional cardiologist specializing in advanced coronary and endovascular interventions. He is the Director of the Pulmonary Embolism Response Team (PERT) at Columbia's Interventional Cardiovascular Careat Columbia University Irving Medical Center/NewYork-Presbyterian Hospital. He performs catheter-based interventions in the coronary artery, pulmonary artery, peripheral arterial, and peripheral venous vascular beds.
He received his medical degree from the Chicago Medical School at Rosalind Franklin University in 2008, graduating Alpha Omega Alpha - the national medical honor society. He completed his residency in Internal Medicine at Mount Sinai Hospital in New York City. Dr. Sethi stayed on at Mount Sinai, simultaneously attaining his MPH degree while completing a residency in Preventive Medicine. He subsequently completed fellowships in Cardiovascular Disease and Interventional Cardiology at UCLA Medical Center. Dr. Sethi then completed a Vascular Medicine and Endovascular Intervention fellowship at Columbia University Irving Medical Center.
Areas of Expertise / Conditions Treated
- Abdominal Aortic Aneurysm
- Atherosclerosis
- Balloon Angioplasty
- Carotid Artery Disease
- Coronary Artery Disease
- Critical Lower Limb Ischaemia
- Deep Vein Thrombosis
- Deep Vein Thrombosis of Iliac Vein
- Endovascular Intervention
- Endovascular Venous Procedures
- Endovenous Laser Ablation
- IVC Filters
- Lower Limb Ischemia
- Mesenteric Ischemia
- Percutaneous Coronary Intervention
- Peripheral Artery Disease (PAD)
- Pulmonary Embolism
- Pulmonary Hypertension
- Renal Vascular Disease
- Varicose Veins
Academic Appointments
- Assistant Professor of Medicine at CUMC
Administrative Titles
- Director of the Pulmonary Embolism Response Team (PERT)
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Male
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Credentials & Experience
Education & Training
- MD, Chicago Medical School at Rosalind Franklin University
- Internship: Mount Sinai Medical Center
- Residency: Mount Sinai Medical Center
- Fellowship: University of California - Los Angeles Medical Center
- Fellowship: Boston Medical Center
- Fellowship: 2017 UCLA Medical Center
Board Certifications
- Public Health and General Preventive Medicine
- Internal Medicine
- Cardiovascular Disease
Research
Dr. Sethi's research interests focus on investigating catheter-based therapies for pulmonary embolism and peripheral arterial disease.
Selected Publications
- INSPIRATION Investigators; Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Jamalkhani S, Khalili H, Yadollahzadeh M, Riahi T, Rezaeifar P, Tahamtan O, Matin S, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Bakhshandeh H, Amin A, Rafiee F, Baghizadeh E, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Dobesh PP, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Bikdeli B. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 Apr 27;325(16):1620-1630. doi: 10.1001/jama.2021.4152. PMID: 33734299; PMCID: PMC7974835.
- Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020 Jul;120(7):1004-1024. doi: 10.1055/s-0040-1713152. Epub 2020 May 30. PMID: 32473596; PMCID: PMC7516364.
- Gupta A, Madhavan MV, Poterucha TJ, DeFilippis EM, Hennessey JA, Redfors B, Eckhardt C, Bikdeli B, Platt J, Nalbandian A, Elias P, Cummings MJ, Nouri SN, Lawlor M, Ranard LS, Li J, Boyle C, Givens R, Brodie D, Krumholz HM, Stone GW, Sethi SS, Burkhoff D, Uriel N, Schwartz A, Leon MB, Kirtane AJ, Wan EY, Parikh SA. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Nat Commun. 2021 Feb 26;12(1):1325. doi: 10.1038/s41467-021-21553-1. PMID: 33637713; PMCID: PMC7910606.
- Farkouh ME, Boden WE, Bittner V, Muratov V, Hartigan P, Ogdie M, Bertolet M, Mathewkutty S, Teo K, Maron DJ, Sethi SS, Domanski M, Frye RL, Fuster V. Risk factor control for coronary artery disease secondary prevention in large randomized trials. J Am Coll Cardiol. 2013 Apr 16;61(15):1607-15. doi: 10.1016/j.jacc.2013.01.044. PMID: 23500281.
- Bikdeli B, Talasaz AH, Rashidi F, Bakhshandeh H, Rafiee F, Rezaeifar P, Baghizadeh E, Matin S, Jamalkhani S, Tahamtan O, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Khalili H, Yadollahzadeh M, Riahi T, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Amin A, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Dobesh PP, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Sadeghipour P. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. Thromb Haemost. 2022 Jan;122(1):131-141. doi: 10.1055/a-1485-2372. Epub 2021 Jun 6. PMID: 33865239.
For a complete list of publications, please visit PubMed.gov